# DAR-901 TB Booster Vaccine to Prevent TB in Adolescents

> **NCT02712424** · PHASE2 · COMPLETED · sponsor: **Dartmouth-Hitchcock Medical Center** · enrollment: 625 (actual)

## Conditions studied

- Tuberculosis

## Interventions

- **BIOLOGICAL:** DAR-901
- **BIOLOGICAL:** Sterile saline placebo

## Key facts

- **NCT ID:** NCT02712424
- **Lead sponsor:** Dartmouth-Hitchcock Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03
- **Primary completion:** 2020-02-01
- **Final completion:** 2020-02-01
- **Target enrollment:** 625 (ACTUAL)
- **Last updated:** 2021-05-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02712424

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02712424, "DAR-901 TB Booster Vaccine to Prevent TB in Adolescents". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02712424. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*